by Rachael Wojcik, FNP-C
For many women, menopause brings a frustrating shift in how the body stores fat, responds to food, and regulates energy. Even with a disciplined lifestyle, weight gain—especially around the midsection—can be extremely frustrating.
When estrogen levels decline in menopause, the body undergoes more than just reproductive changes. It can slow your metabolism, increase fat storage (especially in the belly), affect how your body responds to insulin, and even contribute to fatty liver—something now known as MASLD (Metabolic dysfunction-Associated Steatotic Liver Disease).
Estrogen plays a huge role in how your body handles weight, energy, and inflammation. That’s why many women notice their bodies start changing in ways that feel out of their control after menopause.
GLP-1 receptor agonist medications are a class of peptides that help regulate appetite, support healthy blood sugar levels, promote weight loss, and reduce inflammation. They’re often prescribed for type 2 diabetes, but have gained traction as powerful tools for weight management. Medications like Ozempic (semaglutide) and Zepbound (tirzepatide) can help people feel fuller longer, reduce cravings, and can lead to meaningful fat loss over time. Clinical trials have shown a 15–20% total body weight loss over 12–18 months in many people—especially when combined with lifestyle and nutritional support.
A 2025 study examining the effects of GLP-1 medications in postmenopausal women found that outcomes were significantly enhanced when these therapies were combined with bio-identical hormone replacement. Women receiving both treatments experienced greater fat loss, improved metabolic function, and potentially better liver health compared to those using GLP-1s alone. This synergistic effect is likely due to the fact that estrogen plays a regulatory role in many of the same metabolic pathways targeted by GLP-1s—including insulin sensitivity, fat distribution, liver detoxification, and appetite control.
Supporting this, a 2024 observational study reported that women on combined therapy lost, on average, 4% more total body weight than those on GLP-1 medication alone.
These findings reinforce a broader truth: hormones act as the body’s operating system—governing sleep, mood, metabolism, and energy regulation. When that system is out of balance, even the most disciplined efforts in diet and exercise may not yield the expected results. Restoring hormonal balance can unlock the body’s full capacity to respond, recover, and thrive.
Milani, I., Chinucci, M., Leonetti, F., & Capoccia, D. (2025). MASLD: Prevalence, Mechanisms, and Sex-Based Therapies in Postmenopausal Women. Biomedicines, 13(4), 855. https://doi.org/10.3390/biomedicines13040855
